Virology institute launches Russia's second COVID-19 vaccine human trial - (This is Money via NewsPoints Desk)

  • A Russian state virology institute has started clinical trials of the country's second potential COVID-19 vaccine, injecting the first of five volunteers with a dose on July 27, as reported This is Money on Tuesday.

  • The next participant in the trial by the Vector virology institute in Siberia will receive a dose on July 30.

  • The trial is expected to include 100 volunteers between the ages of 18 and 60.

  • World Health Organization records show that Vector is working on six different potential COVID-19 vaccines.

  • Meanwhile, the Gamaleya Institute completed early clinical trials of an adenovirus-based vaccine earlier this month and expects to enter large-scale trials in August.

To read more NewsPoints articles, click here.